• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P1 噬菌体介导的 CRISPR-Cas9 抗菌活性递送系统对抗.

P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against .

机构信息

School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FF, U.K.

Department of Infection Biology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, U.K.

出版信息

ACS Synth Biol. 2023 Mar 17;12(3):709-721. doi: 10.1021/acssynbio.2c00465. Epub 2023 Feb 20.

DOI:10.1021/acssynbio.2c00465
PMID:36802585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10028697/
Abstract

The discovery of clustered, regularly interspaced, short palindromic repeats (CRISPR) and the Cas9 RNA-guided nuclease provides unprecedented opportunities to selectively kill specific populations or species of bacteria. However, the use of CRISPR-Cas9 to clear bacterial infections is hampered by the inefficient delivery of 9 genetic constructs into bacterial cells. Here, we use a broad-host-range P1-derived phagemid to deliver the CRISPR-Cas9 chromosomal-targeting system into and the dysentery-causing to achieve DNA sequence-specific killing of targeted bacterial cells. We show that genetic modification of the helper P1 phage DNA packaging site () significantly enhances the purity of packaged phagemid and improves the Cas9-mediated killing of cells. We further demonstrate that P1 phage particles can deliver chromosomal-targeting phagemids into using a zebrafish larvae infection model, where they significantly reduce the bacterial load and promote host survival. Our study highlights the potential of combining P1 bacteriophage-based delivery with the CRISPR chromosomal-targeting system to achieve DNA sequence-specific cell lethality and efficient clearance of bacterial infection.

摘要

簇状、规则间隔、短回文重复序列 (CRISPR) 和 Cas9 RNA 指导的核酸酶的发现为有选择地杀死特定的细菌种群或物种提供了前所未有的机会。然而,由于将 9 个基因构建体有效递送至细菌细胞的效率低下,CRISPR-Cas9 用于清除细菌感染受到了阻碍。在这里,我们使用一种广谱宿主范围的 P1 衍生噬菌体来递送 CRISPR-Cas9 染色体靶向系统进入 和引起痢疾的 ,以实现对靶向细菌细胞的 DNA 序列特异性杀伤。我们表明,对辅助 P1 噬菌体 DNA 包装位点()的遗传修饰显著提高了包装噬菌体的纯度,并提高了 Cas9 介导的 细胞杀伤效果。我们进一步证明,P1 噬菌体颗粒可以使用斑马鱼幼虫感染模型将靶向染色体的 噬菌体递送至 ,从而显著降低细菌负荷并促进宿主存活。我们的研究强调了将 P1 噬菌体为基础的递呈与 CRISPR 染色体靶向系统相结合以实现 DNA 序列特异性细胞致死性和有效清除细菌感染的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/7faacd09036c/sb2c00465_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/c48342617b5e/sb2c00465_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/12c65b10bfb1/sb2c00465_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/d15089fceaff/sb2c00465_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/2cd7b03cb2bc/sb2c00465_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/7faacd09036c/sb2c00465_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/c48342617b5e/sb2c00465_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/12c65b10bfb1/sb2c00465_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/d15089fceaff/sb2c00465_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/2cd7b03cb2bc/sb2c00465_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dff5/10028697/7faacd09036c/sb2c00465_0006.jpg

相似文献

1
P1 Bacteriophage-Enabled Delivery of CRISPR-Cas9 Antimicrobial Activity Against .P1 噬菌体介导的 CRISPR-Cas9 抗菌活性递送系统对抗.
ACS Synth Biol. 2023 Mar 17;12(3):709-721. doi: 10.1021/acssynbio.2c00465. Epub 2023 Feb 20.
2
Conjugative delivery of toxin genes and confers synergistic killing of bacterial recipients.毒素基因的接合传递并赋予对细菌受体的协同杀伤作用。
J Bacteriol. 2025 Jul 24;207(7):e0016825. doi: 10.1128/jb.00168-25. Epub 2025 Jul 3.
3
Modulating binding affinity of aptamer-based loading constructs enhances extracellular vesicle-mediated CRISPR/Cas9 delivery.调节基于适配体的装载构建体的结合亲和力可增强细胞外囊泡介导的CRISPR/Cas9递送。
J Control Release. 2025 Aug 10;384:113853. doi: 10.1016/j.jconrel.2025.113853. Epub 2025 May 18.
4
The Role of O-antigen in P1 Transduction of Shigella flexneri and Escherichia coli with its Alternative S' Tail Fibre.O 抗原在 P1 转导中的作用 志贺氏菌和大肠杆菌及其替代 S'尾丝。
J Mol Biol. 2022 Nov 15;434(21):167829. doi: 10.1016/j.jmb.2022.167829. Epub 2022 Sep 15.
5
I-labelled BMSC-Derived Extracellular Vesicles Deliver CRISPR/Cas9 Ribonucleoproteins With a GFP-Reporter System to Inhibit Osteosarcoma Proliferation and Metastasis.I标记的骨髓间充质干细胞衍生的细胞外囊泡通过绿色荧光蛋白报告系统递送CRISPR/Cas9核糖核蛋白以抑制骨肉瘤的增殖和转移。
J Extracell Vesicles. 2025 Jul;14(7):e70130. doi: 10.1002/jev2.70130.
6
Efficient CRISPR/Cas9-mediated ebony gene editing in the greater wax moth Galleria mellonella.高效的CRISPR/Cas9介导的大蜡螟(Galleria mellonella)乌木基因编辑
Insect Sci. 2025 Jun;32(3):833-844. doi: 10.1111/1744-7917.13427. Epub 2024 Aug 9.
7
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy.细胞穿透肽与 CRISPR-Cas9:用于人类遗传疾病治疗的联合策略。
Hum Gene Ther. 2024 Oct;35(19-20):781-797. doi: 10.1089/hum.2024.020.
8
Fitness effects of CRISPR endonucleases in populations.CRISPR 内切酶在种群中的适应性效应。
Elife. 2022 Sep 22;11:e71809. doi: 10.7554/eLife.71809.
9
Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation in the Type I-E CRISPR-Cas System.确定 I 型-E CRISPR-Cas 系统中级联结合、干扰和引物适应的特异性。
mBio. 2018 Apr 17;9(2):e02100-17. doi: 10.1128/mBio.02100-17.
10
Harnessing an anti-CRISPR protein for powering CRISPR/Cas9-mediated genome editing in undomesticated Bacillus strains.利用一种抗CRISPR蛋白在未驯化的芽孢杆菌菌株中推动CRISPR/Cas9介导的基因组编辑。
Microb Cell Fact. 2025 Jun 23;24(1):143. doi: 10.1186/s12934-025-02776-z.

引用本文的文献

1
Synthetic Biology-Based Engineering Living Therapeutics for Antimicrobial Application.基于合成生物学的工程化活体抗菌治疗剂
Exploration (Beijing). 2025 Apr 3;5(4):e20240045. doi: 10.1002/EXP.20240045. eCollection 2025 Aug.
2
Synthetic and Functional Engineering of Bacteriophages: Approaches for Tailored Bactericidal, Diagnostic, and Delivery Platforms.噬菌体的合成与功能工程:定制杀菌、诊断和递送平台的方法
Molecules. 2025 Jul 25;30(15):3132. doi: 10.3390/molecules30153132.
3
A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections.

本文引用的文献

1
Tail-Engineered Phage P2 Enables Delivery of Antimicrobials into Multiple Gut Pathogens.尾部工程化噬菌体 P2 可将抗生素递送至多种肠道病原体。
ACS Synth Biol. 2023 Feb 17;12(2):596-607. doi: 10.1021/acssynbio.2c00615. Epub 2023 Feb 2.
2
The Role of O-antigen in P1 Transduction of Shigella flexneri and Escherichia coli with its Alternative S' Tail Fibre.O 抗原在 P1 转导中的作用 志贺氏菌和大肠杆菌及其替代 S'尾丝。
J Mol Biol. 2022 Nov 15;434(21):167829. doi: 10.1016/j.jmb.2022.167829. Epub 2022 Sep 15.
3
New Insights into the Structure and Assembly of Bacteriophage P1.
噬菌体联合治疗耐药混合细菌感染方法的新见解
Phage (New Rochelle). 2024 Dec 18;5(4):203-222. doi: 10.1089/phage.2024.0011. eCollection 2024 Dec.
4
From resistance to remedy: the role of clustered regularly interspaced short palindromic repeats system in combating antimicrobial resistance-a review.从耐药到补救:成簇规律间隔短回文重复序列系统在对抗抗菌药物耐药性中的作用——综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2259-2273. doi: 10.1007/s00210-024-03509-6. Epub 2024 Oct 15.
5
Engineering probiotic Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system.利用 I 型 CRISPR-Cas 系统工程改造益生菌 Nissle 1917 以阻断多种抗生素耐药基因的转移。
Appl Environ Microbiol. 2024 Oct 23;90(10):e0081124. doi: 10.1128/aem.00811-24. Epub 2024 Sep 10.
6
The untapped potential of phage model systems as therapeutic agents.噬菌体模型系统作为治疗剂的未开发潜力。
Virus Evol. 2024 Jan 13;10(1):veae007. doi: 10.1093/ve/veae007. eCollection 2024.
7
Transcriptional profiling of zebrafish identifies host factors controlling susceptibility to Shigella flexneri.斑马鱼的转录谱分析确定了控制对福氏志贺氏菌易感性的宿主因子。
Dis Model Mech. 2024 Jan 1;17(1). doi: 10.1242/dmm.050431. Epub 2024 Jan 26.
8
Synthesis of a Conjugative System from Human Gut Metagenomic Data for Targeted Delivery of Cas9 Antimicrobials.从人类肠道宏基因组数据中合成一个可共轭系统,用于 Cas9 抗菌药物的靶向投递。
ACS Synth Biol. 2023 Dec 15;12(12):3578-3590. doi: 10.1021/acssynbio.3c00319. Epub 2023 Dec 4.
9
An automated microscopy workflow to study Shigella-neutrophil interactions and antibiotic efficacy in vivo.一种用于研究体内福氏志贺菌与中性粒细胞相互作用和抗生素疗效的自动化显微镜工作流程。
Dis Model Mech. 2023 Jun 1;16(6). doi: 10.1242/dmm.049908. Epub 2023 May 10.
噬菌体 P1 的结构与组装的新见解。
Viruses. 2022 Mar 25;14(4):678. doi: 10.3390/v14040678.
4
Phages and their satellites encode hotspots of antiviral systems.噬菌体及其卫星编码抗病毒系统的热点。
Cell Host Microbe. 2022 May 11;30(5):740-753.e5. doi: 10.1016/j.chom.2022.02.018. Epub 2022 Mar 21.
5
Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome.噬菌体递送 CRISPR-Cas9 用于肠道微生物组中特定菌株的耗竭和基因组缺失。
Cell Rep. 2021 Nov 2;37(5):109930. doi: 10.1016/j.celrep.2021.109930.
6
Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.基于对福氏志贺菌血清型间免疫交叉反应的评估,对广谱志贺菌疫苗的设计进行合理化。
PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009826. doi: 10.1371/journal.pntd.0009826. eCollection 2021 Oct.
7
Engineering Bacteria to Produce Pure Phage-like Particles for Gene Delivery.工程菌生产纯噬菌体样颗粒用于基因传递。
ACS Synth Biol. 2021 Jan 15;10(1):107-114. doi: 10.1021/acssynbio.0c00467. Epub 2020 Dec 14.
8
Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy.流产感染:细菌自杀作为一种抗病毒免疫策略。
Annu Rev Virol. 2020 Sep 29;7(1):371-384. doi: 10.1146/annurev-virology-011620-040628. Epub 2020 Jun 19.
9
Impact of Frequent Administration of Bacteriophage on Therapeutic Efficacy in an Mouse Wound Infection Model.频繁施用噬菌体对小鼠伤口感染模型治疗效果的影响。
Front Microbiol. 2020 Mar 17;11:414. doi: 10.3389/fmicb.2020.00414. eCollection 2020.
10
Shigella sonnei infection of zebrafish reveals that O-antigen mediates neutrophil tolerance and dysentery incidence.宋内志贺菌感染斑马鱼揭示了 O 抗原介导的中性粒细胞耐受和痢疾发生率。
PLoS Pathog. 2019 Dec 12;15(12):e1008006. doi: 10.1371/journal.ppat.1008006. eCollection 2019 Dec.